Home > Journals > Medicine > European Journal of Dermatology > Full text
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
European Journal of Dermatology
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
  Printable version
  Version PDF

The porphyrias: clinical presentation, diagnosis and treatment


European Journal of Dermatology. Volume 16, Number 3, 230-40, May-June 2006, Review article


Summary  

Author(s) : P Poblete-Gutiérrez, T Wiederholt, HF Merk, J Frank , Department of Dermatology, University Hospital Maastricht, The Netherlands, Department of Dermatology, University Hospital of the RWTH Aachen, Germany, Porphyria Center, University Hospital of the RWTH Aachen, Germany.

Summary : The porphyrias comprise a clinically and genetically heterogeneous group of diseases mostly arising from a genetically determined dysfunction of specific enzymes along the pathway of heme biosynthesis. Based on the occurrence or absence of cutaneous symptoms and life-threatening acute neurological attacks, the different types of porphyrias can either be classified into cutaneous and non-cutaneous forms or acute and non-acute forms. Establishing an accurate diagnosis might be difficult for two reasons: i) the porphyrias can manifest with a broad but unspecific spectrum of clinical symptoms mimicking several other disorders, and ii) biochemical examination of urine, feces, and blood can reveal overlapping findings. Fortunately, however, the advances in the fields of molecular genetics during recent years have provided us with the possibility of overcoming these diagnostic pitfalls. Therefore, in controversial cases the correct diagnosis can finally be made using molecular biological techniques. Due to the various facets of the porphyrias, diagnosis and treatment should always imply a close interdisciplinary collaboration to counsel and help patients and their families most efficiently.

Keywords : Porphyria, photosensitivity, acute porphyrias, porphyrinogenic drugs, acute porphyric attack

Pictures

Figure 1 The porphyrin-heme biosynthetic pathway.

Figure 2 A) Blister, miliae, and hyperpigmented scars on the dorsum of the left hand of a patient with porphyria cutanea tarda. B) Lateral view of the same hand,showing a blister, erosions, superficial crusts, and hyperpigmented scars. C) Porphyria cutanea tarda. Detailed view of the dorsal aspect of digitus II and III of a patient: Intact, partially, hemorrhagic blisters, erosions, crusts, and scarring. D) Porphyria cutanea tarda with chronic course: Erosion and sclerodermiform plaques in the neck of a patient.

Figure 3 A) Erythropoietic protoporphyria. Acute photosensitivity reaction with unsharply demarcated erythema and edema on both hands and the wrists of a 10-year-old boy. B) Erythropoietic protoporphyria. Erythema, postinflammatory hyperpigmentation, and erosions in the face of a 9-year-old girl. Note the subtle scarring on the nose.

Figure 4 A) Congenital erythropoietic porphyria. Extensive excoriation, ulceration, and scarring in the face with severe cartilage destruction on the nose resulting in mutilation. Note the partial absence of eyebrows and the complete loss of eye-lashes as well as the hypertrichosis on the right shoulder. B) Congenital erythropoietic porphyria. Erythrodontia due to massive protoporphyrin deposition in the teeth.

Figure 5 Variegate porphyria. Intact blister, erosions, crusts, miliae, and hyperpigmented scarring on the back of the hands. Clinically, the cutaneous lesions can not be distinguished from those encountered in porphyria cutanea tarda.

Figure 6 Algorithm for the diagnosis of the porphyrias based on the prevailing clinical symptoms.


 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]